These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33487431)

  • 1. Trends in the use of hepatitis C viremic donor hearts.
    Li SS; Osho A; Moonsamy P; D'Alessandro DA; Lewis GD; Villavicencio MA; Sundt TM; Funamoto M
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1873-1885.e7. PubMed ID: 33487431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Lung Transplantation From Hepatitis C Viremic Donors.
    Li SS; Osho A; Moonsamy P; Wolfe S; Villavicencio MA; Langer N; Sundt TM; Funamoto M
    Ann Thorac Surg; 2022 May; 113(5):1598-1607. PubMed ID: 34062125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac transplantation from non-viremic hepatitis C donors.
    Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.
    Gidea CG; Narula N; Reyentovich A; Fargnoli A; Smith D; Pavone J; Lewis T; Karpe H; Stachel M; Rao S; Moreira A; Saraon T; Raimann J; Kon Z; Moazami N
    J Heart Lung Transplant; 2020 Nov; 39(11):1199-1207. PubMed ID: 32739334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors.
    Kadosh BS; Birs AS; Flattery E; Stachel M; Hong KN; Xia Y; Gidea C; Aslam S; Razzouk L; Saraon T; Goldberg R; Rao S; Pretorius V; Moazami N; Smith DE; Adler ED; Reyentovich A
    Clin Transplant; 2024 Apr; 38(4):e15294. PubMed ID: 38545881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Use of Hearts From Hepatitis C Viremic Donors.
    Moayedi Y; Fan CPS; Gulamhusein AF; Manlhiot C; Ross HJ; Teuteberg JJ; Khush KK
    Circ Heart Fail; 2018 Dec; 11(12):e005276. PubMed ID: 30562093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.
    Madan S; Patel SR; Vlismas P; Hemmige V; Saeed O; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2021 Nov; 40(11):1382-1386. PubMed ID: 34176726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of acute and chronic rejection in heart transplant recipients from hepatitis C viremic (NAT+) donors.
    Stachel MW; Alimi M; Narula N; Flattery EE; Xia Y; Ramachandran A; Saraon T; Smith D; Reyentovich A; Goldberg R; Kadosh BS; Razzouk L; Katz S; Moazami N; Gidea CG
    Am J Transplant; 2022 Dec; 22(12):2951-2960. PubMed ID: 36053676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors.
    Diaz-Castrillon CE; Huckaby LV; Witer L; Pope NH; Katz MR; Baliga PK; Kilic A
    Clin Transplant; 2022 Apr; 36(4):e14581. PubMed ID: 34974630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of using hepatitis c virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate.
    Gernhofer YK; Brambatti M; Greenberg BH; Adler E; Aslam S; Pretorius V
    J Heart Lung Transplant; 2019 Nov; 38(11):1178-1188. PubMed ID: 31492607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of heart transplantation from hepatitis C virus-positive donors.
    Aslam S; Yumul I; Mariski M; Pretorius V; Adler E
    J Heart Lung Transplant; 2019 Dec; 38(12):1259-1267. PubMed ID: 31521479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
    Mazur RD; Goldberg DS
    Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation.
    Leeaphorn N; Attieh RM; Wadei HM; Mao SA; Mao MA; Pungpapong S; Taner B; Cheungpasitporn W; Jarmi T
    Transplant Proc; 2024; 56(6):1513-1521. PubMed ID: 38997885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C donor viremic cardiac transplantation: A practical approach.
    Morris KL; Adlam JP; Padanilam M; Patel A; Garcia-Cortes R; Chaudhry SP; Seasor E; Tompkins S; Hoefer C; Zanotti G; Walsh MN; Salerno C; Bochan M; Ravichandran A
    Clin Transplant; 2020 Jan; 34(1):e13764. PubMed ID: 31830339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.